Travere Therapeutics
TVTX
TVTX
174 hedge funds and large institutions have $677M invested in Travere Therapeutics in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
+10
Holders Change %
+6.1%
% of All Funds
2.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
64
Reduced
48
Closed
21
Calls
$1.09M
Puts
$5.82M
Net Calls
-$4.73M
Net Calls Change
+$1.55M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$9.69M |
| 2 |
EP
Eversept Partners
New York
|
+$7.37M |
| 3 |
Millennium Management
New York
|
+$7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.72M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.79M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$36.6M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$9.84M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$7.43M |
| 4 |
Goldman Sachs
New York
|
-$5.95M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$5.72M |
